In clinical trials, supplementation of 200 mg/day of CoQ10 significantly reduced TNF-α inflammatory marker, and improved survival in sepsis patients, demonstrating its potential as an adjunct therapy in managing infections [54]. The gene discussed is TNF; the disease is infection.